SCHEMBL6014538

SCHEMBL6014538

CN(C)c1ccc(-c2cnc(-c3ccc(S(=O)(=O)NC(CO)C(O)O)cc3)o2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 4/20 0.48
MMP9 P14780 4/20 0.48
HTR6 P50406 1/20 0.46
NPC1 O15118 4/20 0.40
ALOX15 P16050 2/20 0.40
CASP1 P29466 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
ADRB2 P07550 3/20 0.38
ADRB1 P08588 3/20 0.38
ADRB3 P13945 3/20 0.38
TSHR P16473 1/20 0.36
TP53 P04637 5/20 0.35
MAPT P10636 4/20 0.35
LMNA P02545 4/20 0.35
POLB P06746 1/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
GAA P10253 2/20 0.34
HPGD P15428 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6014530 0.80 HTR6 (0.49) MMP2MMP9HTR6NPC1ALOX15
SCHEMBL6014434 0.80 MMP9 (0.54) MMP2MMP9HTR6NPC1ALOX15
SCHEMBL6014504 0.79 MMP2 (0.50) MMP2MMP9HTR6NPC1ALOX15
SCHEMBL700914 0.79 MMP2 (0.51) MMP2MMP9HTR6NPC1ALOX15
SCHEMBL6014355 0.78 MMP9 (0.48) MMP2MMP9HTR6NPC1ALOX15
SCHEMBL6014725 0.78 CA1 (0.50) MMP2MMP9HTR6NPC1ALOX15
SCHEMBL6014405 0.77 HTR6 (0.48) MMP2MMP9HTR6NPC1ALOX15
SCHEMBL20356911 0.77 CA1 (0.49) MMP2MMP9HTR6NPC1ALOX15
SCHEMBL6014360 0.76 CA1 (0.51) MMP2MMP9HTR6NPC1ALOX15
SCHEMBL12231198 0.76 CA1 (0.51) MMP2MMP9HTR6NPC1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6815445-B2 FOR USE AS FLUORESCENCE DYES AND PROBES Life Technologies Corporation 2004-11-09 US claimed
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-06-05 US claimed
US-7078406-B2 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. (US) 2006-07-18 US disclosed
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes Life Technologies Corporation 2004-12-09 US disclosed
US-6815445-B2 FOR USE AS FLUORESCENCE DYES AND PROBES Life Technologies Corporation 2004-11-09 US disclosed
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 MMP2 3933/4885MMP9 4294/4885HTR6 1602/4885
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes DHFR, FPR1, CYP1A1 MMP2 3933/4885MMP9 4294/4885HTR6 1602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.